Evaluation of Metacognitive Training for Depression in Later Life (MCT-Silver)

Depression Clinical Trial

Official title: A Randomized Controlled Trial Examining the Efficacy of Metacognitive Training for Depression in Later Life (MCT-Silver)

Status Recruiting

Clinical Trial Summary

The study will evaluate the efficacy of metacognitive training for depression in later life (MCT-Silver) vs. cognitive remediation (mybraintraining©) in reducing depressive symptoms among older adults.

Clinical Trial Description

The study examines the efficacy of Metacognitive Training for depression in later life (MCT-Silver). The study intends to investigate the extent to which MCT-Silver leads to a significant reduction in depressive symptoms compared to an active control group (mybraintraining©) (primary outcome: change in clinician-assessed depressive symptoms from t0 to t1 and t2). Secondary outcomes include change in self-reported depressive symptoms and dysfunctional (meta) cognitive beliefs, as well as quality of life, rumination, self-reported anxiety, attitudes toward aging and neuropsychological functioning from t0 to t1 and t2. The study design is a randomized-controlled trial with one intervention group and one active control group. ;

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

• NCT number: NCT03691402
• Study type: Interventional
• Source: Universitätsklinikum Hamburg-Eppendorf
• Contact: Steffen Moritz, phD
• Phone: +49040741056565
• Email: moritz@uke.de
• Status: Recruiting
• Phase: N/A
• Start date: October 2018
• Completion date: September 2020